Hsu, S. P., Kuo, J. S., Chiang, H., Wang, H., Wang, Y., Huang, C., . . . Chi, K. (2018). Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells. Oncotarget.
Stile di citazione ChicagoHsu, Sanford P.C., et al. "Temozolomide, Sirolimus and Chloroquine Is a New Therapeutic Combination That Synergizes to Disrupt Lysosomal Function and Cholesterol Homeostasis in GBM Cells." Oncotarget 2018.
Citazione MLAHsu, Sanford P.C., et al. "Temozolomide, Sirolimus and Chloroquine Is a New Therapeutic Combination That Synergizes to Disrupt Lysosomal Function and Cholesterol Homeostasis in GBM Cells." Oncotarget 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.